The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Size Of The Chlamydia Infection Diagnostics Market In 2026 And How Much Will It Reach By 2030?
The chlamydia infection diagnostics market size has experienced rapid growth in recent years. This market is projected to expand from $1.4 billion in 2025 to $1.56 billion in 2026, registering a compound annual growth rate (CAGR) of 11.5%. This past growth can be attributed to factors such as the expansion of laboratory infrastructure, the rising incidence of chlamydia infections, an increased use of molecular diagnostics, growth in clinical testing volumes, and the availability of standardized diagnostic protocols.
The chlamydia infection diagnostics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $2.39 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. The expansion during this outlook period is driven by a rising need for swift and automated diagnostic solutions, increased capital allocation towards laboratory automation, the proliferation of decentralized diagnostic testing, a heightened emphasis on detecting infections early, and ongoing advancements in molecular testing technologies. Key developments expected during the forecast timeframe encompass the wider implementation of sophisticated molecular diagnostic platforms, a surge in the uptake of PCR and LAMP-based assays, increased incorporation of automation within diagnostic laboratories, an increase in high-throughput screening capacities, and a sharpened emphasis on diagnostic precision and velocity.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18296&type=smp
Which Growth Factors Are Strengthening The Chlamydia Infection Diagnostics Market Landscape?
The increasing emphasis on preventive healthcare is anticipated to drive growth in the chlamydia infection diagnostics market. This approach focuses on measures to avert illnesses rather than addressing them post-onset, incorporating routine examinations, immunizations, and changes in lifestyle. The heightened attention on preventive healthcare seeks to lower medical expenses, enhance overall well-being, and avert chronic conditions via prompt identification and proactive health strategies. Its significance in chlamydia diagnostics lies in stressing early identification, patient education, and routine screenings, all of which contribute to mitigating the spread and associated complications of chlamydia. For example, in May 2023, data from the National Health Service (NHS), the UK’s publicly funded healthcare system, indicated approximately 23.02 million diagnostic tests were carried out in March 2023, marking an increase of 223,100 tests compared to March 2022. Furthermore, in March 2023, the total number of patients on waiting lists for crucial diagnostic tests reached 16.28 million, an increment of 59,400 from March 2022. Thus, the intensified focus on preventive healthcare is a key driver for the expansion of the chlamydia infection diagnostics market.
Which Segment Groups Define The Chlamydia Infection Diagnostics Market Landscape?
The chlamydia infection diagnostics market covered in this report is segmented –
1) By Test Type: Culture Test, Nucleic Acid Amplification Test (NAAT), Direct Fluorescent Antibody Test, Serology Test, Other Test Types
2) By Type Of Infections: Genital Chlamydia Infection, Rectal Chlamydia Infection, Ocular Chlamydia Infection
3) By Application: Hospitals, Specialty Clinics, Diagnostic Centers
4) By End User: Diagnostics, Therapeutics
Subsegments:
1) By Culture Test: Cell Culture, Egg Culture
2) By Nucleic Acid Amplification Test (NAAT): PCR-Based Test, LAMP-Based Test
3) By Direct Fluorescent Antibody Test: Direct Fluorescent Antibody Staining, Direct Fluorescent In-Situ Hybridization
4) By Serology Test: Immunoassays, Enzyme Immunoassay (EIA)
5) By Other Test Types: Enzyme-Linked Immunosorbent Assay (ELISA), Hybrid Capture Test
Which Trends Are Shaping The Chlamydia Infection Diagnostics Market Landscape?
Leading companies within the chlamydia infection diagnostic market are directing their efforts toward creating advanced products, such as molecular point-of-care testing platforms, to secure a competitive advantage. These molecular point-of-care (POC) testing platforms function as diagnostic instruments designed to identify and analyze specific nucleic acids (DNA or RNA) from pathogens directly at the patient care site. For example, in May 2024, Sherlock Biosciences, a US based biotech company, announced the development of its Sherlock test, positioning it as one of the initial molecular disposable tests for Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (NG). The results from this diagnostic test are provided in under 30-minutes, based on the analysis of DNA and RNA self-collected via penile meatal or vaginal swabs.
Who Are The Businesses Driving Activity In The Chlamydia Infection Diagnostics Market?
Major companies operating in the chlamydia infection diagnostics market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Cepheid, Meridian Bioscience Inc., Sekisui Diagnostics, Copan Diagnostics
Access The Complete Chlamydia Infection Diagnostics Market Report:
Which Region Contributes The Most To The Chlamydia Infection Diagnostics Market?
North America was the largest region in the chlamydia infection diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chlamydia infection diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Chlamydia Infection Diagnostics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=18296&type=smp
Browse Through More Reports Similar to the Global Chlamydia Infection Diagnostics Market 2026, By The Business Research Company
Chlamydia Infection Diagnostics Global Market Report 2026
Chlamydia Infection Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/chlamydia-infection-treatment-global-market-report
Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model